Release Date: 20/11/18 09:53 Summary: Operations Restructure Update Price Sensitive: Yes Download Document 139.81KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%